Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A new lead in treating chronic social defeat stress

Published on: 24/05/2017 Reading time: 1 min
Une personne en dépression
Retour à la recherche

24Chronic social defeat stress is a cause in many cases of depression. In humans, chronic social stress is built over time based on our past social interaction, with numerous consequences on both a psychological and neurological level.

Beyond depression, many patients display cognitive disorders including memory and attention loss, and complicated decision-making. Current therapy is focused on treating depression, yet its impact on cognitive deficiency remains unclear.

Institut du Cerveau - ICM researchers focused on the behavioral and molecular impact of chronic social defeat stress in an experimental model summarizing similar symptoms to those observed in humans. They also studied the effect of a molecule named agomelatine that has demonstrated antidepressant and anxiolytic effects.

In addition to behavioral modifications and memory disorders observed in animals, researchers highlighted a decrease in the expression of certain genes of the hippocampus, an area of the brain that plays a crucial role in memory and known to be directly affected in social stress. Results showed that agomelatine has an effect on cognitive disorders and gene expression in the hippocampus.

This data suggests that agomelatine may be of particular interest in treating cognitive disorders associated with depression. Complementary studies will focus on studying the molecule’s mechanisms.

Sources

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
https://www.nature.com/articles/srep45907
Martin V, Allaïli N, Euvrard M, Marday T, Riffaud A, Franc B, Mocaër E, Gabriel C, Fossati P, Lehericy S, Lanfumey L. Sci Rep. 2017 Apr 4;8:45907

Our news on the subject

Les ondes lentes de l’éveil
Sleep-like slow waves: early sentinels of Alzheimer’s disease?
What if the risk of developing Alzheimer’s disease could be assessed with an EEG? Pierre Champetier and his colleagues in the DreamTeam think the idea is worth taking seriously. In a study published in Alzheimer’s & Dementia, the team shows that slow...
09.07.2026 Research, science & health
Hypertension intracrânienne idiopathique
Idiopathic intracranial hypertension: the role of cerebral venous flow revealed
Sometimes, doctors cannot find the cause of intracranial hypertension, a syndrome characterized by excess pressure inside the skull. Patients’ symptoms are effectively relieved by a procedure that dilates a vein in the brain… yet no one truly...
07.22.2026 Research, science & health
motoneurones
Parkinson's disease, multiple sclerosis, ALS: behind the rising case numbers, distinct dynamics
The number of patients living with neurodegenerative diseases that affect movement is rising steadily across Europe. Yet a large-scale study from the Paris Brain Institute and the Karolinska Institutet in Stockholm shows that this is not an emerging...
06.08.2026 Research, science & health
Microtubules in vitro. Crédit : Paul Appleton, Université de Dundee.
When physics sheds new light on brain diseases
For decades, cell biology has built its approach around the study of genes and molecules, pushing the physical forces that sculpt our tissues into the background. Today, an international consortium, coordinated by Fanny Mochel at the Paris Brain...
05.26.2026 Research, science & health
Rêver éveillé : les états oniriques ne sont pas réservés au sommeil
Dreaming while awake: dream-like states are not confined to sleep
We tend to take for granted that the thoughts associated with sleep have a particular quality: we often describe them as elusive, abstract, or marked by a certain strangeness. Yet a study conducted by researchers from the DreamTeam at the Paris Brain...
04.29.2026 Research, science & health
Représentation artistique des neurones. Crédit : Odra Noël.
How the architecture of the prefrontal cortex shapes our creativity
The cognitive and neural mechanisms underlying creative thinking are still poorly understood. A new study from the FrontLab team at the Paris Brain Institute explores this question from an original angle by examining creativity where it sometimes...
04.22.2026 Research, science & health
See all our news